MedPath

To Study the effect of Lifestyle modification with special reference to aharvidhividhan and Bhojanottarvidhi vidhan( Rules of dietic)on Agnimandya

Phase 2
Not yet recruiting
Conditions
Diseases of the digestive system. Ayurveda Condition: Agnimandya, (2) ICD-10 Condition: K929||Disease of digestive system, unspecified. Ayurveda Condition: MANDAGNIH/ AGNISADA, (3) ICD-10 Condition: K929||Disease of digestive system, unspecified. Ayurveda Condition: Agnimandya,
Registration Number
CTRI/2022/08/045093
Lead Sponsor
Vidarbha Ayurved Mahavidyalaya Amravati
Brief Summary

A Randomized clinical trial will be conducted to study the effect of Lifestyle modification with special reference to Aharvidhividhan and Bhojanottar vidhividhan on Agnimandya. Trial will be conducted in our Institute . total 120 patients with Inclusive Criteria having Signs and symptoms of Agnimandya  will be selected and will be divided in two groups. one group will be advised Lifestyle modifications i.e Aharvidhividhan and Bhojanottar vidhividhan  and other group will be observed only. and result will be compared. Primary outcome will be about Evaluation of Lifestyle distrubance  and the Secondary Outcome will be about assessment criteria of effect of therapy. and results will be noted

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria
  • subject having signs and symptoms of agnimandya like avipak, prasek, kshudhamandya, Shirogaurav, Amashay pradeshi gaurav, Shirogaurav, Antrakujan, Pravahan, malbaddhata, Jaran shakti, Abhyavharan Shakti, Mala samata patient having any 2 or more symptoms among these.
  • having symptoms not more than 2 months.
Exclusion Criteria
  • patient age less than 20 and more than 60 years, patients diagnosed with any pathology of GIT such as Cancer of GIT, Liver, pancreas, gall bladder, peptic and gastric ulcer, gastro-esophageal reflux, gall stone, renal failure, hepatitis, tuberculosis will be excluded.
  • pregnant and lactating mother, people not ready to give written consent, and not ready to change their lifestyle due to occupation or duties.
  • Agnimandya caused due to medicine intake.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete Remission from Agnimandya 76-100%0th day | 3rd Day | 7th Day | 14th Day | 21st Day | 28th Day | 35th Day | 42nd Day | 49th Day | 56th Day | 63th Day | 70th Day
mild improvement in Agnimandya 25-50%0th day | 3rd Day | 7th Day | 14th Day | 21st Day | 28th Day | 35th Day | 42nd Day | 49th Day | 56th Day | 63th Day | 70th Day
Marked Improvement in Agnimandya 51-75%0th day | 3rd Day | 7th Day | 14th Day | 21st Day | 28th Day | 35th Day | 42nd Day | 49th Day | 56th Day | 63th Day | 70th Day
Secondary Outcome Measures
NameTimeMethod
Remission in symptoms of anaemiaRemission in symptoms of obesity

Trial Locations

Locations (1)

Vidarbha Ayurved Mahavidyalaya and Hospital Amravati

🇮🇳

Amravati, MAHARASHTRA, India

Vidarbha Ayurved Mahavidyalaya and Hospital Amravati
🇮🇳Amravati, MAHARASHTRA, India
Pallavi Narendra Agrakar
Principal investigator
9834645280
drpallaviagarkar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.